Hem › Lungcancer › Connecticut › New Haven
Kliniska studier för Lungcancer i New Haven, CT
22 studier för Lungcancer söker deltagare vid platser i och runt New Haven (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekryterarFas 3
- Yale University, New Haven
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 mi bort
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi bort
- och 2 fler
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekryterarFas 1/2
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekryterarFas 2
- Yale Cancer Center, New Haven
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RekryterarFas 3
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 mi bort
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RekryterarFas 3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi bort
- Smilow Cancer Hospital-Derby Care Center, Derby · 8 mi bort
- och 1 fler
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RekryterarFas 3
- Yale University, Smillow Cancer Center, New Haven
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
RekryterarFas 1
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- och 1 fler
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
RekryterarFas 2
- Research Site, New Haven
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RekryterarFas 1
- Yale Cancer Center, New Haven
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
RekryterarFas 1/2
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi bort
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RekryterarFas 1/2
- Yale University School of Medicine - Yale Cancer Center, New Haven
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekryterarFas 3
- Yale University School of Medicine, New Haven
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RekryterarFas 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
RekryterarFas 1
- Yale Cancer Center, New Haven
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RekryterarFas 1
- Xencor Investigative Site, New Haven
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
RekryterarFas 1/2
- Yale University Cancer Center, New Haven
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekryterarFas 2
- Yale University, New Haven
- Smilow Cancer Hospital-Orange Care Center, Orange · 5 mi bort
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi bort
- och 2 fler
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekryterarFas 1
- Smilow Cancer Hospital (Yale University), New Haven
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekryterarFas 2
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi bort
- Smilow Cancer Hospital-Derby Care Center, Derby · 8 mi bort
- och 1 fler
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekryterarFas 2/3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi bort
- Smilow Cancer Hospital-Derby Care Center, Derby · 8 mi bort
- och 1 fler
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
RekryterarFriska volontärer välkomna
- Yale New Haven Medical Center, New Haven
The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)
RekryterarObservationsstudie
- Yale School of Medicine, New Haven
Lungcancer-studier i andra städer
- Houston, TX78 studier
- Boston, MA62 studier
- New York City, NY60 studier
- Los Angeles, CA45 studier
- Washington, DC41 studier
- Arlington, VA41 studier
- Chicago, IL41 studier
- Nashville, TN40 studier
- Baltimore, MD40 studier
- St. Louis, MO39 studier
- Columbus, OH37 studier
- Philadelphia, PA36 studier
Andra studier i New Haven
- Icke-småcellig lungcancer41 studier
- Bröstcancer37 studier
- Cancer (alla typer)33 studier
- Metastaserande cancer23 studier
- Plattenepitelcancer i huvud och hals22 studier
- Äggstockscancer21 studier
- Kolorektal cancer20 studier
- Prostatacancer20 studier
- Opioidöverdos18 studier
- Alkoholmissbruk (AUD)17 studier
- Akut myeloid leukemi17 studier
- Bukspottkörtelcancer16 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.